car-t
Sanofi and Celgene Spend $20 Billion in Major Biotech Acquisitions
Sanofi and Celgene Spend $20 Billion in Major Biotech Acquisitions
Katarina Zimmer | Jan 23, 2018
Pharmaceutical giant Sanofi to take over hemophilia drugmaker Biovertiv, while Celgene will buy cancer drugmaker Juno Therapeutics.
CAR T-Cell Trials Boast Promising Results
CAR T-Cell Trials Boast Promising Results
Diana Kwon | Jun 5, 2017
The results of two small clinical trials show that the immunotherapy is effective for multiple myeloma patients, at least in the near term.
Novartis Drops Gene Therapy Research
Novartis Drops Gene Therapy Research
Ben Andrew Henry | Sep 6, 2016
The company has shuttered its experimental cell and gene cancer therapy unit, firing more than 100 researchers.
Cancer Immunotherapy Trial Suspended After Deaths
Cancer Immunotherapy Trial Suspended After Deaths
Kerry Grens | Jul 8, 2016
Juno Therapeutics asks the US Food and Drug Administration for permission to restart the CAR-T experiments without chemotherapy.
TS Picks: March 16, 2016
TS Picks: March 16, 2016
Kerry Grens | Mar 16, 2016
Corrections give belated credit for immunotherapy; mosquitoes have been bugging us long before Zika; the bright side of irreproducibility